Progressive Fibrosing Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Progressive Fibrosing Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients [Phase 2]
Phase 2 clinical trial investigating HEC585 to delay decline in forced vital capacity in progressive fibrosing interstitial lung disease, cu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. [NA]
A clinical trial is evaluating whether quercetin intake benefits patients with fibrotic interstitial lung diseases, including idiopathic pul…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) [Phase 2]
A Phase 2 clinical trial evaluating ENV-101 for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease is listed …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anlotinib Capsules in the Treatment for IPF/PF-ILDs [Phase 2, Phase 3]
Clinical trial update on Anlotinib capsules for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. The Phase…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis [Phase 1]
This clinical trial update describes a Phase 1 study evaluating autologous lung stem cell transplantation for idiopathic pulmonary fibrosis …
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) [Phase 3]
Phase 3 trial evaluating BI 1015550 for progressive fibrosing interstitial lung diseases has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis [Phase 2]
Phase II randomized, double-blind study evaluating HRS-9813 for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung di…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
A clinical trial update shows that the University of Aarhus is evaluating hyperpolarized 129-Xenon MRI in progressive fibrosing interstitial…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
A clinical trial update from Taiwan reports long-term outcomes for people with progressive fibrosing interstitial lung diseases who started …
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis [Phase 3]
A Phase 3 trial in China tested nintedanib for progressive lung fibrosis, with results posted in May 2025.
-
CLINICAL_TRIALS withdrawal · 2025-02-24Clinical Trial Update: Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease [Phase 3]
Phase 3 trial of nintedanib for progressive fibrosing coal mine dust-induced interstitial lung disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases [Phase 2, Phase 3]
This clinical trial update notes a Phase 2/3 study evaluating olokizumab for progressive fibrosing interstitial lung diseases, and the trial…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment
Boehringer Ingelheim conducted a study on progression to progressive fibrosing interstitial lung disease (PF-ILD) and how it is managed and …
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) [Phase 3]
A Phase 3 follow-up study on long-term treatment with nintedanib in progressive fibrosing interstitial lung disease has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) [Phase 3]
Phase 3 trial update reporting efficacy and safety of nintedanib in progressive fibrosing interstitial lung disease (PF-ILD).
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease [Phase 2]
Phase 2 trial update for pirfenidone in unclassifiable progressive fibrosing interstitial lung disease completed with posted results.